 elucidating the pathogenesis and altered protein expression in TSC-associated lesions in humans and in the Tsc murine models and in defining the molecular, clinical and histological characteristics of NF-associated lesions in humans and murine models. Finally, the delivery and effect of gene therapy on lesions in Tsc and Nf2 mouse models
elucidating the pathogenesis and altered protein expression in TSC - associated lesion in world and in the Tsc murine models and in defining the molecular, clinical and histological characteristics of NF - consort lesions in humans and murine exemplar. Finally, the delivery and consequence of gene therapy on lesions in Tsc and Nf2 mouse model
 elkcidating the pathogenesls and altered ptorein eepressikn in TSZ-associated lesions in humand qnd ib the Tsc murine modelr and in fefining the nolecular, rminical and hjdtolmjical characterlstics of NX-associated leviund in humans and murine models. Finaljy, the cepivery and effgct og gens therapy on lesions in Tsc and Nf2 mouse kodels
elucidating the pathogenesis and altered protein expression lesions humans and the Tsc murine molecular, and histological characteristics NF-associated lesions in and murine models. Finally, the delivery effect of gene therapy on lesions in Tsc and Nf2 mouse models
 elucidating the pathogenesiS and altereD protEin ExpReSsioN in TsC-associated leSIons In humans and in the Tsc murIne moDeLS and IN dEfiniNg the moLEcULAr, cLiNiCal AnD HiStoloGicAl charaCteristics Of Nf-aSsociated lesIOnS in humans aNd mUrine models. FInaLly, the DeLivERy and EffEct of Gene thERapy on Lesions in tsC And Nf2 mOUse modeLS
 elucidating the pathogene sis and al tered  pr ote in  exp ress ion in TSC-ass o ciat ed lesions in humans a nd in  t h e Ts c  m urine  models an d inde fi nin gt he  mole cul ar, cli nical andhis to logical char a ct eristics o f N F-associated  le sionsin  hu m ans a ndmurin e mode l s. Fin ally, the  d e livery and eff e c tof g ene therapy on le s io n s in Tsc and N f2 mou se mo d e ls
 elucidating_the pathogenesis_and altered protein expression_in TSC-associated_lesions_in humans_and_in the Tsc_murine models and_in defining the molecular,_clinical and histological_characteristics_of NF-associated lesions in humans and murine models. Finally, the delivery and effect of_gene_therapy on_lesions_in_Tsc and Nf2 mouse models